A New Frontier at the Intersection of Metabolism and Mental Health Glucagon-like peptide-1 (GLP-1) receptor agonists have shifted from a...
For sponsors and CROs, the gap between protocol design and trial execution often hinges on site performance. As clinical trials...
This checklist is a practical tool for clinical development professionals at sponsor and CRO organizations. It reflects regulatory guidance (FDA,...
Diabetes, obesity, heart failure, chronic kidney disease, and atherosclerosis often overlap, creating layered eligibility barriers that complicate patient enrollment in...
Clinical trials are the engine of medical progress, yet in dermatology, their velocity is often hindered by operational friction. While...
Skin conditions are among the most common health issues worldwide, increasing the demand for effective, long-lasting treatments. In the US,...
As clinical studies become more complex and timelines contract, clinical research sites face pressure to deliver high-quality data, remain compliant,...
Conducting clinical trials in Type 2 Diabetes (T2D) presents a unique set of challenges at the site level. Sites are...
As the vaccine industry advances, recruiting participants for clinical trials becomes more complex. Clinical development professionals face challenges such as...
High screen failure rates in central nervous system (CNS), neurological, and psychiatric clinical trials are among the most significant barriers...